環狀RNA合成市場規模、佔有率和成長分析：按產品類型、合成方法、應用、最終用戶、規模、分銷管道和地區分類－2026-2033年產業預測

2024 年全球 circRNA 合成市場價值為 4.2 億美元，預計到 2025 年將從 4.9812 億美元成長到 2033 年的 19.499 億美元，在預測期（2026-2033 年）內以 18.6% 的複合年成長率成長。

全球環狀RNA（circRNA）合成市場在核酸治療領域正迅速發展，這主要得益於人們對circRNA穩定性和調控功能的日益重視。隨著高通量定序技術的進步，大量內源性circRNA已被解析，生物技術公司目前正優先開發用於circRNA生產的酵素試劑盒等合成平台。這一轉變凸顯了該市場的重要性，它將生物學見解轉化為可用於診斷和治療（例如疫苗和基因編輯）的可操作流程。由於circRNA相比mRNA具有更高的穩定性，合成試劑盒的普及正在推動對基於circRNA的療法（尤其是疫苗研發）的投資。此外，人工智慧驅動的自動化正在提高效率並縮短研發週期，隨著產業適應先進的製造和品質控制技術，這將加速投資和市場成長。

全球環狀RNA合成市場促進因素

由於酵素連接和自動化RNA組裝等合成生物學技術的進步，全球環狀RNA（circRNA）合成市場正經歷顯著成長。這些進步使研究人員能夠以更高的精度和效率建立環狀RNA，從而簡化實驗流程並最大限度地減少資源消耗。因此，這些技術在學術機構和工業實驗室中的應用日益廣泛。高品質circRNA構建體的生產能力提升了其在治療研究、診斷技術創新和功能研究中的應用潛力，從而拓展了其應用範圍。此外，這些進步降低了中小型生物技術公司的進入門檻，促進了競爭性創新，並加速了商業化進程。

全球環狀RNA合成市場面臨的限制因素

生產高純度環狀RNA需要使用特化酶、最佳化反應條件和完善的純化工藝，這顯著增加了生產成本。這些財務壓力給尋求市場准入的小規模機構帶來了挑戰，並最終影響終端用戶的定價策略，尤其是在預算有限的學術領域。因此，經濟障礙會阻礙這些創新技術的廣泛應用，延緩有前景的環狀RNA研究成果轉化為可上市產品的進程，並限制整體市場成長。此外，這些財務限制也阻礙了對該領域研發的長期投入。

全球環狀RNA合成市場趨勢

全球環狀RNA（circRNA）合成市場正經歷一場變革，而人工智慧（AI）技術的進步正是推動這項變革的關鍵因素。 AI平台透過自動化序列最佳化和脫靶分析等關鍵任務，顯著提高了circRNA合成的效率。這項技術的整合使研究人員能夠大幅縮短實驗迭代所需的時間，從而加速研發週期。高通量篩檢結合機器學習，能夠快速辨識有效的構建體，促進生技公司與計算科學專家之間的合作。因此，這一趨勢不僅加快了候選療法的上市速度，也推動了對創新疾病標靶和臨床應用探索的投資。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球環狀RNA合成市場規模：依產品類型分類

• 環狀RNA合成試劑盒
• 環狀RNA試劑
• 客製化環狀RNA合成服務

全球環狀RNA合成市場規模：依合成方法分類

• 體外移植
• 酵素環化
• 化學合成

全球環狀RNA合成市場規模：依應用領域分類

• 藥物發現
• 疫苗研發
• 基礎研究
• 其他

全球環狀RNA合成市場規模：依最終用戶分類

• 製藥公司
• 生技公司
• 學術研究機構
• 其他

全球環狀RNA合成市場規模：依市場規模分類

• 研究級
• GMP級

全球環狀RNA合成市場規模：依分銷管道分類

• 直銷
• 銷售代理
• 其他

全球環狀RNA合成市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GenScript Biotech Corporation
• TriLink BioTechnologies
• VectorBuilder Inc.
• Creative Biogene
• Creative Biolabs
• Sino Biological, Inc.
• BioCat GmbH
• New England Biolabs, Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• ST Pharm Co., Ltd.
• GeneCopoeia, Inc.
• Aldevron LLC
• Azenta Life Sciences
• ACROBiosystems
• Takara Bio Inc.
• Genewiz（Azenta）
• OriGene Technologies, Inc.
• Bio-Synthesis Inc.
• Synbio Technologies

結論與建議

Global Circrna Synthesis Market size was valued at USD 420.0 Million in 2024 and is poised to grow from USD 498.12 Million in 2025 to USD 1949.9 Million by 2033, growing at a CAGR of 18.6% during the forecast period (2026-2033).

The global circular RNA (circRNA) synthesis market is rapidly evolving within the nucleic-acid therapeutics sector, spurred by the increasing recognition of circRNA's stability and regulatory functions. Following advancements in high-throughput sequencing that uncovered numerous endogenous circRNAs, biotech firms are now prioritizing synthetic platforms, offering enzymatic kits for circRNA production. This transition emphasizes the market's significance, transforming biological insights into viable pipelines for diagnostics and therapeutics like vaccines and gene editing. The availability of synthesis kits supports investment in circRNA-based therapies, particularly in vaccine development due to circRNA's resilience compared to mRNA. Additionally, AI-driven automation is enhancing efficiency and reducing development timelines, driving accelerated investment and market growth as the industry adapts to advanced manufacturing and quality monitoring technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circrna Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circrna Synthesis Market Segments Analysis

Global circrna synthesis market is segmented by product type, synthesis method, application, end user, scale, distribution channel and region. Based on product type, the market is segmented into circRNA Synthesis Kits, circRNA Reagents and Custom circRNA Synthesis Services. Based on synthesis method, the market is segmented into In Vitro Transcription, Enzymatic Circularization and Chemical Synthesis. Based on application, the market is segmented into Drug Discovery, Vaccine Development, Basic Research and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes and Others. Based on scale, the market is segmented into Research Grade and GMP Grade. Based on distribution channel, the market is segmented into Direct Sales, Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circrna Synthesis Market

The Global Circrna Synthesis market is experiencing significant growth due to advancements in synthetic biology techniques, including enzymatic ligation and automated RNA assembly. These developments allow researchers to create circular RNAs with greater accuracy and efficiency, streamlining experimental workflows and minimizing resource consumption. As a result, there's an increasing adoption of these technologies in both academic and industrial laboratories. The ability to produce high-quality circRNA constructs enhances interest in therapeutic research, diagnostic innovations, and functional studies, thereby broadening the scope of applications. Furthermore, these improvements reduce entry barriers for smaller biotech companies, promoting competitive innovation and speeding up commercialization processes.

Restraints in the Global Circrna Synthesis Market

The production of high-purity circular RNAs necessitates the use of specialized enzymes, tailored reaction conditions, and thorough purification processes, which significantly increase manufacturing costs. These financial pressures pose challenges for smaller organizations seeking to enter the market, ultimately affecting pricing strategies for end users, especially in academic environments where budgets are tight. As a result, the economic barriers hinder widespread adoption of these innovative technologies and may delay the conversion of promising circular RNA advancements into market-ready products, restricting overall market growth. Furthermore, these financial constraints deter long-term commitments to research and development efforts in the field.

Market Trends of the Global Circrna Synthesis Market

The global circRNA synthesis market is experiencing a transformative shift driven by advancements in artificial intelligence. AI platforms are enhancing the efficiency of circRNA synthesis processes by automating critical tasks such as sequence optimization and off-target analysis. This technological integration allows researchers to significantly reduce the time required for experimental iterations, fostering quicker development cycles. High-throughput screening combined with machine learning facilitates the rapid identification of viable constructs, promoting collaboration between biotech firms and computational experts. As a result, this trend not only accelerates the journey of therapeutic candidates to market but also encourages investments in innovative disease targets and exploration of clinical applications.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global CircRNA Synthesis Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• circRNA Synthesis Kits
• circRNA Reagents
• Custom circRNA Synthesis Services

Global CircRNA Synthesis Market Size by Synthesis Method & CAGR (2026-2033)

• Market Overview
• In Vitro Transcription
• Enzymatic Circularization
• Chemical Synthesis

Global CircRNA Synthesis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Vaccine Development
• Basic Research
• Others

Global CircRNA Synthesis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes
• Others

Global CircRNA Synthesis Market Size by Scale & CAGR (2026-2033)

• Market Overview
• Research Grade
• GMP Grade

Global CircRNA Synthesis Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors
• Others

Global CircRNA Synthesis Market Size & CAGR (2026-2033)

• North America (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Synthesis Method, Application, End User, Scale, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriLink BioTechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VectorBuilder Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCat GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ST Pharm Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aldevron LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACROBiosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (Azenta)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Synthesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations